Joel S. Marcus

Companies

• Alexandria Real Estate EquitiesBoard member 1994 to now⁷
• Alexandria Real Estate EquitiesChair 1994 to now⁸
• Intra-Cellular Therapies, Inc.Board member Sep 18, 2013 to Apr 2, 2025⁹
• Applied Therapeutics, Inc.Board member May 13, 2019 to Jun 7, 2024¹⁰
• Korro Bio, Inc.Board member Oct 2, 2019 to Aug 19, 2022¹¹
• MeiraGTx Holdings plcBoard member Jun 8, 2018 to Jun 9, 2022¹²
• Atara Biotherapeutics, Inc.Board member Oct 15, 2014 to Mar 19, 2019¹³
• Alexandria Real Estate EquitiesChief executive officer Jan 23, 2006 to Apr 2, 2018¹⁴
• Rexford Industrial RealtyBoard member Jul 18, 2013 to Jun 3, 2014¹⁵
• PennyMac Mortgage Investment TrustBoard member Aug 5, 2009 to May 18, 2012¹⁶
• Alexandria Real Estate EquitiesFounder 1994¹⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Alexandria Real Estate Equities ARE597,724 shares¹⁸$24.0M at $40.19Sep 11, 2026
• ICIntra-Cellular Therapies, Inc.0 shares¹⁹Apr 2, 2025
• ATApplied Therapeutics, Inc.565,849 shares²⁰Jun 6, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 11, 2026Bought 5,000 shares at $49.68 of Alexandria Real Estate Equities¹⁸
• Aug 17, 2026Bought 5,000 shares at $46.28 of Alexandria Real Estate Equities²¹
• May 6, 2026Bought 3,511 shares at $46.74 of Alexandria Real Estate Equities²²
• May 6, 2026Bought 3,989 shares at $45.99 of Alexandria Real Estate Equities²²
• May 5, 2026Bought 1,606 shares at $43.70 of Alexandria Real Estate Equities²³
• May 5, 2026Bought 3,832 shares at $42.76 of Alexandria Real Estate Equities²³
• May 5, 2026Bought 2,062 shares at $41.89 of Alexandria Real Estate Equities²³
• May 4, 2026Bought 10,000 shares at $41.02 of Alexandria Real Estate Equities²⁴
• Feb 12, 2026Bought 7,700 shares at $54.31 of Alexandria Real Estate Equities²⁵
• Feb 12, 2026Bought 17,300 shares at $53.74 of Alexandria Real Estate Equities²⁵
• Jan 23, 2026Returned to company 35,075 shares of Alexandria Real Estate Equities²⁶
• Jan 22, 2026Returned to company 14,671 shares of Alexandria Real Estate Equities²⁶
• Jan 9, 2026Granted 100,056 shares of Alexandria Real Estate Equities²⁷
• Jan 2, 2026Granted 31,270 shares of Alexandria Real Estate Equities²⁸
• Apr 2, 2025Returned to company 10,000 shares at $132.00 of Intra-Cellular Therapies, Inc.¹⁹
• Apr 2, 2025Returned to company 48,238 shares at $132.00 of Intra-Cellular Therapies, Inc.¹⁹
• Feb 24, 2025Exercised options 7,009 shares at $63.79 of Intra-Cellular Therapies, Inc.²⁹
• Jan 10, 2025Granted 46,207 shares of Alexandria Real Estate Equities³⁰
• Jan 2, 2025Granted 15,610 shares of Alexandria Real Estate Equities³¹
• Dec 31, 2024Returned to company 19,156 shares of Alexandria Real Estate Equities³¹
• Jun 23, 2024Exercised options 1,567 shares of Intra-Cellular Therapies, Inc.³²
• Jun 6, 2024Granted 45,000 shares of Applied Therapeutics, Inc.²⁰
• Mar 29, 2024Shares withheld for tax 5,400 shares at $128.91 of Alexandria Real Estate Equities³³
• Mar 29, 2024Returned to company 10,655 shares of Alexandria Real Estate Equities³³
• Feb 26, 2024Sold 299 shares at $69.60 of Intra-Cellular Therapies, Inc.³⁴